The Supreme Court Just Made It Easier for You to Get Cheaper Generic Drugs—With 1 Major Catch

The Supreme Court's decision to support generic drugmaker Hikma means brand-name drug companies will find it more challenging to halt the introduction of cheaper alternatives. This ruling could lead to more affordable medications for consumers, but a pharmaceutical patent lawyer warns that the legal tug-of-war is not over yet. This move is significant as it could reshape the landscape of drug pricing and accessibility, potentially benefiting millions who rely on generics for essential treatments. However, ongoing legal battles suggest that the path to broader, cheaper medication access remains complicated.